With the use of VprBP inhibitor B32B3, we also confirmed a major role of VprBP-mediated H2AT20p in inactivating growth-regulatory genes as well as stimulating melanoma tumor growth in vivo. This evidence concerns the gene DCAF1 and melanoma.